Couldn't load pickup availability
Tirzepatide is a next-generation weight loss medication, FDA-approved through Mounjaro® that helps people shed stubborn weight by targeting both appetite and blood sugar. It works by activating two powerful hormones (GLP-1 and GIP) to reduce cravings, improve metabolism, and support long-term fat loss.
Originally developed for type 2 diabetes, Tirzepatide has shown exceptional results in helping people lose up to 20% of their body weight. For many, it’s a breakthrough option when diet and exercise alone haven’t been enough.
Tirzepatide mimics the actions of both GLP-1 and GIP, two naturally occurring hormones that help manage blood sugar and control hunger. By slowing down digestion and signaling fullness to the brain, it helps reduce cravings and calorie intake, leading to steady, sustainable weight loss.
Some patients report reduced appetite and early weight loss within the first 2–4 weeks. More significant results typically appear by 8–12 weeks. Clinical trials have shown average weight loss of up to 22.5% of body weight when tirzepatide is combined with diet and exercise.*
*In the 72-week SURMOUNT-1 trial, adults with a BMI ≥30 or ≥27 with at least one weight-related condition (and without diabetes) lost an average of 15–22.5% of their body weight, depending on dose. By comparison, those who relied on lifestyle changes alone lost an average of 2.4%.
Your Tirzepatide kit comes with everything you need:
- Your personalized treatment (as prescribed by your doctor)
- Syringes
- Alcohol pads
- Thermal bag
- Ice pack for safe delivery.
It also includes free 24/7 provider messaging, formula adjustments, and regular check-ins to keep your treatment on track.
And of course a thorough instruction manual so you can start confidently and follow each step with ease.
Watch our step-by-step instructions to help you start and continue your treatment with confidence.
Read important safety information about Tirzepazide® here.
A mandatory doctor consultation is required before starting treatment, and the cost will be added to your cart. During the consultation, you will receive training from our doctor and detailed usage information to ensure you can safely prepare your dose for self-administration. Our weight loss medications are intended for patients with a BMI ≥30 kg/m² or ≥27 with at least one weight-related comorbidity. Patients with type 1 diabetes are not eligible for treatment. You may use our BMI calculator to check your eligibility or consult our doctors to determine suitability for treatment.
Our tirzepatide is compounded by a licensed pharmacy. It is not FDA-approved and is prescribed case-by-case when appropriate; use only under clinician supervision.
Tirzepatide is one of the most advanced weight loss medications available today. FDA-approved through Mounjaro® and trusted by doctors to deliver real, sustainable results.
It activates both GLP-1 and GIP receptors, giving it a dual-action edge over semaglutide by helping you control appetite, regulate blood sugar, and burn fat more effectively.
Through our compounded option, you get the same active ingredient in a more affordable, personalized dose which is prepared by licensed compounding pharmacies and ready to ship.
Like all medications, it carries potential serious side effects: including a risk of thyroid tumors. Do not use tirzepatide if you or your family has a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). For full safety details, please read the complete prescribing information here.
Safe, high-quality care is our priority. That’s why &you partners only with FDA-registered pharmacies using ingredients from FDA-regulated suppliers, ensuring strict compliance and quality standards for compounded medication.
Our suppliers undergo rigorous quality checks by an accredited third-party lab to verify consistency, potency, and sterility. A Certificate of Analysis is available for access at any time.
